The financials
ICU Medical, Inc. by the numbers
ICU Medical, Inc. (ICUI) reported revenue of $530M in Q1 2026 (quarter ended Mar 31, 2026), down 12% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $30M (5.7% of revenue). For the full year FY2025, revenue was $2.23B (−6.3% year on year) and net income $732K. Its largest product in Jun 2026 was Infusion Consumables at $289M, 52% of the disclosed total, ahead of Infusion Systems at 34%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $530M | $605M | −12% |
| Gross profit | $206M | $210M | −1.8% |
| Operating income | $14M | $13M | +5.4% |
| Net income | $30M | −$15M | to a profit |
| Diluted EPS | $1.20 | −$0.63 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Infusion Consumables | $289M | 52% |
| Infusion Systems | $189M | 34% |
| Vital Care | $73M | 13% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $551.7M (+4.0%)
Infusion Systems grew +13% year on yearVital Care -32% year on year
Segment Latestquarter on quarteryear on year
- Infusion Consumables$289.3M$289.3MQoQ +4.0%year on year +5.9%+4.0%+5.9%
- Infusion Systems$189.0M$189.0MQoQ +5.2%year on year +13%+5.2%+13%
- Vital Care$73.4M$73.4MQoQ +1.5%year on year -32%+1.5%-32%
Medical Instruments & Supplies
Ranks #17 of 19 by Smart Score